Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Polymer-free sirolimus-eluting stents in a large-scale all-comers population.

Krackhardt F, Kočka V, Waliszewski MW, Utech A, Lustermann M, Hudec M, Studenčan M, Schwefer M, Yu J, Jeong MH, Ahn T, Wan Ahmad WA, Boxberger M, Schneider A, Leschke M.

Open Heart. 2017 Jun 6;4(2):e000592. doi: 10.1136/openhrt-2017-000592. eCollection 2017.

2.

Cangrelor With and Without Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Percutaneous Coronary Intervention.

Vaduganathan M, Harrington RA, Stone GW, Deliargyris EN, Steg PG, Gibson CM, Hamm CW, Price MJ, Menozzi A, Prats J, Elkin S, Mahaffey KW, White HD, Bhatt DL; CHAMPION Investigators.

J Am Coll Cardiol. 2017 Jan 17;69(2):176-185. doi: 10.1016/j.jacc.2016.10.055.

PMID:
28081827
3.

Invasive Hemodynamic Assessment of Cardiac Output State after MitraClip Therapy in Nonanaesthetized Patients with Functional Mitral Regurgitation.

Bednar F, Budesinsky T, Linkova H, Kocka V.

Biomed Res Int. 2016;2016:6296972. doi: 10.1155/2016/6296972. Epub 2016 Dec 12.

4.

Periprocedural antithrombotic therapy during various types of percutaneous cardiovascular interventions.

Widimský P, Kočka V, Roháč F, Osmančík P.

Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):131-40. doi: 10.1093/ehjcvp/pvv053. Epub 2015 Dec 11. Review.

5.

Long-term follow-up after bioresorbable vascular scaffold implantation in STEMI patients: PRAGUE-19 study update.

Toušek P, Kočka V, Malý M, Kozel M, Petr R, Hajsl M, Jarkovský J, Lisa L, Buděšínský T, Widimský P.

EuroIntervention. 2016 May 17;12(1):23-9. doi: 10.4244/EIJV12I1A5.

6.

Degenerative changes and immune response after transcatheter aortic valve implantation. Comparison with surgical aortic valve replacement.

Sulženko J, Toušek P, Kočka V, Bednář F, Línková H, Petr R, Laboš M, Widimský P.

J Cardiol. 2017 Feb;69(2):483-488. doi: 10.1016/j.jjcc.2016.03.009. Epub 2016 Apr 23.

PMID:
27117541
7.

ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Ortega-Paz L, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Giacchi G, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.

Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7. No abstract available.

PMID:
27096965
8.

Bioresorbable vascular scaffolds in STEMI patients: multimodality imaging comparison in mid-term perspective.

Marchese G, Petr R, Tousek P, Widimsky P, Kocka V.

Minerva Cardioangiol. 2016 Aug;64(4):411-8. Epub 2016 Apr 12.

PMID:
27070202
9.

Two-year follow-up after bioresorbable vascular scaffold implantation in STEMI patients - Results from PRAGUE-19 study.

Toušek P, Kočka V, Malý M, Kozel M, Robert P, Hajšl M, Jarkovský J, Widimský P.

Int J Cardiol. 2016 Apr 15;209:20-1. doi: 10.1016/j.ijcard.2016.02.029. Epub 2016 Feb 3. No abstract available.

PMID:
26878467
10.

Manual aspiration thrombectomy devices use in coronary interventions in 2016.

Kočka V, Toušek P.

Expert Rev Med Devices. 2016;13(3):243-51. doi: 10.1586/17434440.2016.1146586. Epub 2016 Feb 20. Review.

PMID:
26808609
11.

One-Year Clinical and Computed Tomography Angiographic Outcomes After Bioresorbable Vascular Scaffold Implantation During Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction: The PRAGUE-19 Study.

Widimsky P, Petr R, Tousek P, Maly M, Linkova H, Vrana J, Hajsl M, Budesinsky T, Lisa L, Kocka V.

Circ Cardiovasc Interv. 2015 Dec;8(12):e002933. doi: 10.1161/CIRCINTERVENTIONS.115.002933.

12.

Absorb bioresorbable stents for the treatment of coronary artery disease.

Kočka V, Toušek P, Widimský P.

Expert Rev Med Devices. 2015;12(5):545-57. doi: 10.1586/17434440.2015.1080119. Review.

PMID:
26305838
13.

Transcatheter aortic valve implantation: long-term clinical outcome and valve durability.

Sulzenko J, Tousek P, Kocka V, Widimsky P.

Expert Rev Med Devices. 2015;12(5):529-35. doi: 10.1586/17434440.2015.1063994. Epub 2015 Jul 3.

PMID:
26134100
14.

Culprit lesion thrombus burden after manual thrombectomy or percutaneous coronary intervention-alone in ST-segment elevation myocardial infarction: the optical coherence tomography sub-study of the TOTAL (ThrOmbecTomy versus PCI ALone) trial.

Bhindi R, Kajander OA, Jolly SS, Kassam S, Lavi S, Niemelä K, Fung A, Cheema AN, Meeks B, Alexopoulos D, Kočka V, Cantor WJ, Kaivosoja TP, Shestakovska O, Gao P, Stankovic G, Džavík V, Sheth T.

Eur Heart J. 2015 Aug 1;36(29):1892-900. doi: 10.1093/eurheartj/ehv176. Epub 2015 May 20.

15.

Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.

Toušek P, Kočka V, Malý M, Lisa L, Buděšínský T, Widimský P.

Heart Vessels. 2016 Jun;31(6):841-5. doi: 10.1007/s00380-015-0679-8. Epub 2015 Apr 21.

PMID:
25896128
16.

Potential role of invariant natural killer T cells in outcomes of acute myocardial infarction.

Novak J, Dobrovolny J, Tousek P, Kocka V, Teringova E, Novakova L, Widimsky P.

Int J Cardiol. 2015;187:663-5. doi: 10.1016/j.ijcard.2015.03.398. Epub 2015 Mar 28. No abstract available.

PMID:
25880406
17.

Randomized trial of primary PCI with or without routine manual thrombectomy.

Jolly SS, Cairns JA, Yusuf S, Meeks B, Pogue J, Rokoss MJ, Kedev S, Thabane L, Stankovic G, Moreno R, Gershlick A, Chowdhary S, Lavi S, Niemelä K, Steg PG, Bernat I, Xu Y, Cantor WJ, Overgaard CB, Naber CK, Cheema AN, Welsh RC, Bertrand OF, Avezum A, Bhindi R, Pancholy S, Rao SV, Natarajan MK, ten Berg JM, Shestakovska O, Gao P, Widimsky P, Džavík V; TOTAL Investigators.

N Engl J Med. 2015 Apr 9;372(15):1389-98. doi: 10.1056/NEJMoa1415098. Epub 2015 Mar 16.

18.

How should I treat subacute stent thrombosis in the context of brain haemorrhage with abciximab?

Martin-Yuste V, Alvarez-Contreras L, Sabaté M, Kelbaek H, Saunamäki K, Jørgensen E, Kocka V.

EuroIntervention. 2015 Feb;10(10):e1-6. doi: 10.4244/EIJV10I10A208. No abstract available.

19.

Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).

Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M.

JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005. Erratum in: JACC Cardiovasc Interv. 2015 Mar;8(3):503.

20.

[The user´s reporting from the national registry of catheter aortic valve implantations (Czech TAVI Registry): the possibilities of the analytical reports based on the database system TrialDB2].

Bláha M, Kala P, Klimeš D, Bernat I, Branny M, Cervinka P, Horák J, Kočka V, Mates M, Němec P, Pešl L, Stípal R, Sťásek J, Zelízko M.

Vnitr Lek. 2014 Oct;60(10):837-45. Review. Czech.

PMID:
25382006

Supplemental Content

Loading ...
Support Center